These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29507061)

  • 1. Metabolism, Excretion, and Mass Balance of Solithromycin in Humans.
    MacLauchlin C; Schneider SE; Keedy K; Fernandes P; Jamieson BD
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29507061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.
    Zhanel GG; Hartel E; Adam H; Zelenitsky S; Zhanel MA; Golden A; Schweizer F; Gorityala B; Lagacé-Wiens PR; Walkty AJ; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2016 Dec; 76(18):1737-1757. PubMed ID: 27909995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solithromycin: A novel ketolide antibiotic.
    Buege MJ; Brown JE; Aitken SL
    Am J Health Syst Pharm; 2017 Jun; 74(12):875-887. PubMed ID: 28432048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic/Pharmacodynamic Evaluation of Solithromycin against Streptococcus pneumoniae Using Data from a Neutropenic Murine Lung Infection Model.
    Okusanya OO; Forrest A; Bhavnani SM; Fernandes P; Ambrose PG; Andes DR
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leveraging Physiologically Based Pharmacokinetic Modeling and Experimental Data to Guide Dosing Modification of CYP3A-Mediated Drug-Drug Interactions in the Pediatric Population.
    Salerno SN; Carreño FO; Edginton AN; Cohen-Wolkowiez M; Gonzalez D
    Drug Metab Dispos; 2021 Sep; 49(9):844-855. PubMed ID: 34154994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solithromycin for the treatment of community-acquired bacterial pneumonia.
    Viasus D; Ramos O; Ramos L; Simonetti AF; Carratalà J
    Expert Rev Respir Med; 2017 Jan; 11(1):5-12. PubMed ID: 27753516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an Adult Physiologically Based Pharmacokinetic Model of Solithromycin in Plasma and Epithelial Lining Fluid.
    Salerno SN; Edginton A; Cohen-Wolkowiez M; Hornik CP; Watt KM; Jamieson BD; Gonzalez D
    CPT Pharmacometrics Syst Pharmacol; 2017 Dec; 6(12):814-822. PubMed ID: 29068158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia.
    File TM; Rewerska B; Vucinic-Mihailovic V; Gonong JRV; Das AF; Keedy K; Taylor D; Sheets A; Fernandes P; Oldach D; Jamieson BD
    Clin Infect Dis; 2016 Oct; 63(8):1007-1016. PubMed ID: 27448679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blind, multicenter phase 2 study comparing the efficacy and safety of oral solithromycin (CEM-101) to those of oral levofloxacin in the treatment of patients with community-acquired bacterial pneumonia.
    Oldach D; Clark K; Schranz J; Das A; Craft JC; Scott D; Jamieson BD; Fernandes P
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2526-34. PubMed ID: 23507282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects.
    Still JG; Schranz J; Degenhardt TP; Scott D; Fernandes P; Gutierrez MJ; Clark K
    Antimicrob Agents Chemother; 2011 May; 55(5):1997-2003. PubMed ID: 21282444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of solithromycin and its metabolites, CEM-214 and N-acetyl-CEM-101, against 100 clinical Ureaplasma spp. isolates compared with azithromycin.
    Furfaro LL; Spiller OB; Keelan JA; Payne MS
    Int J Antimicrob Agents; 2015 Sep; 46(3):319-24. PubMed ID: 26141231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL).
    Barrera CM; Mykietiuk A; Metev H; Nitu MF; Karimjee N; Doreski PA; Mitha I; Tanaseanu CM; Molina JM; Antonovsky Y; Van Rensburg DJ; Rowe BH; Flores-Figueroa J; Rewerska B; Clark K; Keedy K; Sheets A; Scott D; Horwith G; Das AF; Jamieson B; Fernandes P; Oldach D;
    Lancet Infect Dis; 2016 Apr; 16(4):421-30. PubMed ID: 26852726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal administration of solithromycin, a new, potent, broad-spectrum fluoroketolide antibiotic, achieves fetal and intra-amniotic antimicrobial protection in a pregnant sheep model.
    Keelan JA; Kemp MW; Payne MS; Johnson D; Stock SJ; Saito M; Fernandes P; Newnham JP
    Antimicrob Agents Chemother; 2014; 58(1):447-54. PubMed ID: 24189250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy.
    Donald BJ; Surani S; Deol HS; Mbadugha UJ; Udeani G
    Drug Des Devel Ther; 2017; 11():3559-3566. PubMed ID: 29263651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of solithromycin in the management of bacterial community-acquired pneumonia.
    Van Bambeke F; Tulkens PM
    Expert Rev Anti Infect Ther; 2016; 14(3):311-24. PubMed ID: 26848612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of plasma, epithelial lining fluid, and alveolar macrophage concentrations of solithromycin (CEM-101) in healthy adult subjects.
    Rodvold KA; Gotfried MH; Still JG; Clark K; Fernandes P
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5076-81. PubMed ID: 22802254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and excretion of the dipeptidyl peptidase 4 inhibitor [14C]sitagliptin in humans.
    Vincent SH; Reed JR; Bergman AJ; Elmore CS; Zhu B; Xu S; Ebel D; Larson P; Zeng W; Chen L; Dilzer S; Lasseter K; Gottesdiener K; Wagner JA; Herman GA
    Drug Metab Dispos; 2007 Apr; 35(4):533-8. PubMed ID: 17220239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of the activity of solithromycin (CEM-101) against bacteria from respiratory tract infections.
    Hawser S; Morrissey I; Lemos B; Keedy K; Fernandes P
    Int J Antimicrob Agents; 2017 Jul; 50(1):17-22. PubMed ID: 28483717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results from the Solithromycin International Surveillance Program (2014).
    Farrell DJ; Flamm RK; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3662-8. PubMed ID: 27044551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Pharmacokinetics of Solithromycin in Subjects with Hepatic Impairment.
    Jamieson BD; Ciric S; Fernandes P
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4379-86. PubMed ID: 25870056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.